Published in BMC Neurol on April 11, 2012
Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K/Akt pathway in the hippocampus of neonatal rats. PLoS One (2014) 1.10
Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation. J Transl Med (2013) 0.96
The effects of 2 µg and 4 µg doses of dexmedetomidine in combination with intrathecal hyperbaric bupivacaine on spinal anesthesia and its postoperative analgesic characteristics. Pain Res Manag (2014) 0.92
Dexmedetomidine post-treatment induces neuroprotection via activation of extracellular signal-regulated kinase in rats with subarachnoid haemorrhage. Br J Anaesth (2016) 0.84
Study of cell apoptosis in the hippocampus and thalamencephalon in a ventricular fluid impact model. Exp Ther Med (2013) 0.78
Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro. Neurobiol Aging (2015) 0.77
Organotypic Hippocampal Slices as Models for Stroke and Traumatic Brain Injury. Mol Neurobiol (2015) 0.76
Effects of COX inhibition and LPS on formalin induced pain in the infant rat. Dev Neurobiol (2014) 0.75
Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection. Cell Death Dis (2016) 0.75
Desflurane impairs outcome of organotypic hippocampal slices in an in vitro model of traumatic brain injury. Med Gas Res (2016) 0.75
Dexmedetomidine: what next? Ann Transl Med (2016) 0.75
Low dose dexmedetomidine for the prophylaxis of perioperative ICU delirium-how much evidence is enough? J Thorac Dis (2016) 0.75
α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury. Oncotarget (2016) 0.75
Dexmedetomidine Protects Against Glucocorticoid Induced Progenitor Cell Apoptosis in Neonatal Mouse Cerebellum. J Matern Fetal Neonatal Med (2016) 0.75
Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med (2002) 21.40
A simple method for organotypic cultures of nervous tissue. J Neurosci Methods (1991) 14.18
Traumatic brain injury in the United States: A public health perspective. J Head Trauma Rehabil (1999) 5.31
The epidemiology of traumatic brain injury. J Head Trauma Rehabil (2010) 2.15
Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003. J Head Trauma Rehabil (2008) 1.94
The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med (2008) 1.81
Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr Drug Targets CNS Neurol Disord (2005) 1.64
Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol (2004) 1.54
Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand (2009) 1.50
Time course of synaptic development in hippocampal organotypic cultures. Brain Res Dev Brain Res (1993) 1.45
Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care (2009) 1.40
The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg (2003) 1.34
In vitro central nervous system models of mechanically induced trauma: a review. J Neurotrauma (1998) 1.27
Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology (1991) 1.22
The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801. J Neurosci (1992) 1.19
Rapid NMDA receptor phosphorylation and oxidative stress precede striatal neurodegeneration after hypoxic ischemia in newborn piglets and are attenuated with hypothermia. Int J Dev Neurosci (2007) 1.14
Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors. Anesthesiology (2008) 1.12
Neuroprotective effects of a combination of dexmedetomidine and hypothermia after incomplete cerebral ischemia in rats. Acta Anaesthesiol Scand (2009) 1.10
Methods to induce primary and secondary traumatic damage in organotypic hippocampal slice cultures. Brain Res Brain Res Protoc (2000) 1.08
ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. Invest Ophthalmol Vis Sci (2009) 1.03
Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Anesthesiology (2002) 1.03
Propofol: neuroprotection in an in vitro model of traumatic brain injury. Crit Care (2009) 1.01
The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype. Anesth Analg (2006) 0.99
Functional validation of adult hippocampal organotypic cultures as an in vitro model of brain injury. Brain Res (2004) 0.98
ERK 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons. J Cell Biochem (2007) 0.87
Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury. BMC Neurol (2010) 0.86
Characterization of the postconditioning effect of dexmedetomidine in mouse organotypic hippocampal slice cultures exposed to oxygen and glucose deprivation. Anesthesiology (2010) 0.85
Activation of the mitogen-activated protein kinase (ERK(1/2)) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. Mol Pharmacol (2002) 0.85
Effect of mild and moderate hypothermia on hypoxic injury in nearly pure neuronal culture. J Anesth (2010) 0.80
Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med (2008) 19.93
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med (2005) 8.55
A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery. N Engl J Med (2015) 4.22
PML in a patient treated with fumaric acid. N Engl J Med (2013) 3.87
Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care (2013) 3.65
Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma (2005) 3.22
Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med (2007) 2.97
Nonmalignant late effects after allogeneic stem cell transplantation. Blood (2003) 2.95
MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain (2006) 2.77
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst (2011) 2.56
Practice and perception--a nationwide survey of therapy habits in sepsis. Crit Care Med (2008) 2.43
Management of bleeding following major trauma: a European guideline. Crit Care (2007) 2.40
Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy. Nat Genet (2005) 2.38
Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia (2005) 2.37
Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci (2010) 2.25
The intraoperative decrease of selenium is associated with the postoperative development of multiorgan dysfunction in cardiac surgical patients. Crit Care Med (2011) 2.21
Evidence-based medicine in the therapy of the acute respiratory distress syndrome. Intensive Care Med (2002) 2.16
Continuous right ventricular volumetry by fast-response thermodilution during right ventricular ischemia: head-to-head comparison with conductance catheter measurements. Crit Care Med (2009) 1.96
Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol (2003) 1.92
Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol (2013) 1.87
Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med (2011) 1.85
Airway reactions and emergence times in general laryngeal mask airway anaesthesia: a meta-analysis. Eur J Anaesthesiol (2015) 1.83
Repairing injured peripheral nerves: Bridging the gap. Prog Neurobiol (2010) 1.77
IL-6 is required for glioma development in a mouse model. Oncogene (2004) 1.74
Dynamic preload indicators fail to predict fluid responsiveness in open-chest conditions. Crit Care Med (2009) 1.72
Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit Care Med (2008) 1.70
The small GTPase Rab7 controls the endosomal trafficking and neuritogenic signaling of the nerve growth factor receptor TrkA. J Neurosci (2005) 1.69
Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer (2005) 1.67
Pumpless extracorporeal lung assist for protective mechanical ventilation in experimental lung injury. Crit Care Med (2007) 1.66
A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet (2013) 1.61
Effects of partial ventilatory support modalities on respiratory function in severe hypoxemic lung injury. Crit Care Med (2006) 1.60
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective. Crit Care (2006) 1.58
Levosimendan but not norepinephrine improves microvascular oxygenation during experimental septic shock. Crit Care Med (2008) 1.57
Combining xenon and mild therapeutic hypothermia preserves neurological function after prolonged cardiac arrest in pigs. Crit Care Med (2012) 1.53
Chronic augmentation of the parasympathetic tone to the atrioventricular node: a nonthoracotomy neurostimulation technique for ventricular rate control during atrial fibrillation. J Cardiovasc Electrophysiol (2009) 1.51
Ventilation with biphasic positive airway pressure in experimental lung injury. Influence of transpulmonary pressure on gas exchange and haemodynamics. Intensive Care Med (2004) 1.50
Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4. Am J Hum Genet (2007) 1.50
S-100 protein and neurohistopathologic changes in a porcine model of acute lung injury. Anesthesiology (2005) 1.50
Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model. Crit Care (2014) 1.49
Repeated generation of the pulmonary pressure-volume curve may lead to derecruitment in experimental lung injury. Intensive Care Med (2004) 1.48
Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Crit Care Med (2007) 1.48
Reducing the duration of 100% oxygen ventilation in the early reperfusion period after cardiopulmonary resuscitation decreases striatal brain damage. Resuscitation (2010) 1.44
Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain (2009) 1.44
Early modifiable factors associated with fatal outcome in patients with severe traumatic brain injury: a case control study. Crit Care Med (2007) 1.43
Anesthesia and neurotoxicity in the developing brain: A non-systematic review. Acta Anaesthesiol Belg (2015) 1.43
Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet (2010) 1.42
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma. J Exp Med (2010) 1.41
High-frequency oscillatory ventilation in experimental lung injury: effects on gas exchange. Intensive Care Med (2002) 1.41
Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity. Crit Care (2011) 1.40
Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care (2009) 1.40
SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system. Proc Natl Acad Sci U S A (2009) 1.39
Neurological emergencies as causes of accidents. Eur J Emerg Med (2005) 1.38
Sevoflurane exposure prevents diaphragmatic oxidative stress during mechanical ventilation but reduces force and affects protein metabolism even during spontaneous breathing in a rat model. Anesth Analg (2015) 1.38
SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome. Brain (2013) 1.29
Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev Neurobiol (2007) 1.29
Validation of a new arterial pulse contour-based cardiac output device. Crit Care Med (2007) 1.25
Implantation and explantation of a wireless epiretinal retina implant device: observations during the EPIRET3 prospective clinical trial. Invest Ophthalmol Vis Sci (2009) 1.21
Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. J Clin Oncol (2006) 1.20
New visual feedback device improves performance of chest compressions by professionals in simulated cardiac arrest. Resuscitation (2009) 1.18
Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord (2010) 1.17
Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet (2009) 1.16
Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol (2006) 1.16
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer (2010) 1.15
Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy. J Neurol (2013) 1.14
Augmentation of left ventricular contractility by cardiac sympathetic neural stimulation. Circulation (2010) 1.12
Feasibility of prehospital teleconsultation in acute stroke--a pilot study in clinical routine. PLoS One (2012) 1.12
Post-mortem forensic neuroimaging: correlation of MSCT and MRI findings with autopsy results. Forensic Sci Int (2007) 1.11
Age-dependent axonal degeneration in an Alzheimer mouse model. Neurobiol Aging (2006) 1.10
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer (2013) 1.10
Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome. Am J Med Genet A (2007) 1.09
The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. Eur J Pharmacol (2011) 1.08
Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia. Ann Neurol (2007) 1.08
In vitro assessment of axonal growth using dorsal root ganglia explants in a novel three-dimensional collagen matrix. Tissue Eng (2007) 1.07
Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery. Anesthesiology (2007) 1.07
Ablation of Dicer from murine Schwann cells increases their proliferation while blocking myelination. PLoS One (2010) 1.07
Major confounders may influence multivariate analysis in a single-center observational study. Crit Care Med (2014) 1.06
Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study. Crit Care (2009) 1.05
Clinical validation of a new thermodilution system for the assessment of cardiac output and volumetric parameters. Crit Care (2012) 1.05
Minimal instructions improve the performance of laypersons in the use of semiautomatic and automatic external defibrillators. Crit Care (2005) 1.03
[Treatment of Acute Central Retinal Artery Occlusion (CRAO) by Hyperbaric Oxygenation Therapy (HBO)--Pilot study with 21 patients]. Klin Monbl Augenheilkd (2002) 1.03
Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med (2003) 1.02
Differential endocytic sorting of p75NTR and TrkA in response to NGF: a role for late endosomes in TrkA trafficking. Mol Cell Neurosci (2005) 1.02
Propofol: neuroprotection in an in vitro model of traumatic brain injury. Crit Care (2009) 1.01